Comparison of Efficacy of Fractional CO2 Laser with Intralesional Steroid Versus Intralesional Steroid Alone in the Treatment of Keloids
Keywords:
Keloids, triamcinolone acetonide (TAC),, fractional carbon dioxide (FCO2)Abstract
Background: Keloids are abnormal wound responses characterized by deposition of excessive collagen and glycoprotein. They are distressing for most of the patients symptomatically and aesthetically. Intralesional steroids are the most commonly used treatment for keloids. Fractional CO2 laser is an emerging therapeutic option for keloids which can be used alone or as combination with other therapies. Objective: To compare the efficacy of fractional CO2 laser with intralesional steroid versus intralesional steroid alone in the treatment of keloids. Methods: Sixty patients were randomly assigned into two groups (30 patients each). After applying topical anesthesia to patients, Group A received fractional CO2 laser sessions followed by intralesional triamcinolone acetonide (TAC) with a gap of 5 mins every 4th week for total 4 months. Group B received Intralesional TAC alone every 4th week for total 4 months. Efficacy was assessed at the end of 4th session and was labelled if there was grade 3 or grade 4 improvement in width and height of keloid, degree of hypertrophy, dyschromia and texture of keloid using modified quartile score. Results: Total of 60 patients (30 in each group) were recruited. The mean age was 26.60 ± 5.52 years in group A and 29.76 ± 6.20 years in group B. We found that efficacy was 90% (n=27) in Group A and 66.6% (n=20) in Group B with (P-value-0.028). Conclusion: Our study results demonstrated that fractional CO2 laser in combination with intralesional TAC has better efficacy as compared to intralesional TAC alone, with a statistically significant difference (P-value-0.028).References
O’Toole EA, Mellerio JE. Wound healing. In: Burns T, ed. Rook’s Textbook of Dermatology. 8th Edn. West Sussex, UK: Wiley‐Blackwell; 2010:14‐15.
Jucket G, Adams HH. Management of Keloids and Hypertrophic Scars. Am Fam Physician. 2009;80(3): 253-60. PMID: 19621835.
Sun LM, Wang KH, Lee YC. Keloid incidence in Asian people and its comorbidity with other fibro-sis-related diseases: a nationwide population-based study. Arch Dermatol Res. 2014;306(9):803-8. Doi: 10.1007/s00403-014-1491-5.
Asilian A, Daroughen A, Shariati F. New combina-tion of triamcinolone, 5‐fluorouracil and pulsed‐dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32(7):907‐15. Doi: 10.1111/j.1524-4725.2006.32195.x
Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2005:71:3-8. Doi: 10.4103/0378-6323.13777
Marco Coppola M, Salzillo R, Segreto F, Persichetti P. Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018; 11: 387–96. Doi: 10.2147/CCID.S133672.
Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Rame-let AA, Shakespeare PG, et al. International Adviso-ry Panel on Scar Management. International clini-cal recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-71. Doi: 10.1097/00006534-200208000-00031
Munaluchi G, Suzuki S, Onodera M, Ito O, Hata Y, Igawa HH. Long-term outcome of intralesional inj-ection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006;40(2):111–16.
Doi: 10.1080/02844310500430003.
Ahsan Q, Sikder UA, Khondker L. Efficacy of com-bination of intralesional corticosteroid injection and cryotherapy versus intralesional corticosteroid injection alone in patients of keloid. J Pak Assoc Dermatol. 2018; 28(4): 474-81.
Prabhu A, Sreekar H, Power R, Uppin VM. A ran-domized controlled trial comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc. 2012; 39:19-25.
Trisliana Perdanasari A, Torresetti M, Grassetti L, Nicoli F, Zhang YX, Dashti T, et al . Intralesional in-jection treatment of hypertrophic scars and keloids: a systematic review regarding outcomes. Burns Trauma. 2015;3:14. Doi: 10.1186/s41038-015-0015-7.
Waibel J, Beer K, Narurkar V, Alster T. Preliminary observations on fractional ablative resurfacing dev-ices: Clinical impressions. J Drugs Dermatol 2009; 8:481–85. PMID: 19537372.
Nouri K, Vidulich K, Rivas MP. Lasers for scars: a review. J Cosmet Dermatol. 2006;5(1):14–22. Doi: 10.1111/j.1473-2165.2006.00217.x.
NH. Sahib, MK Al-hattab, FA Fakhry, IJ Atiyah. The Role of Fractional CO2 Laser in Treatment of Keloid and Hypertrophic Scar used Alone and in Combi-nation with Intralesional Steroids: Indian J Foren Med Toxicol, 2020;14(3):1576-81.
Alexander S, Girisha BS, Sripathi H, Noronha TM, Alva AC. Efficacy of fractional CO2 laser with intr-alesional steroid compared with intralesional ster-oid alone in the treatment of keloids and hyper-trophic scars. J Cosmet Dermatol. 2019;18(6): 1648-1656.
Doi: 10.1111/jocd.12887
Kumar K, Kapoor BS, Rai P, Shukla HS. In-situ ir-radiation of keloid scars with Nd:YAG laser. J Wound Care. 2000;9(5):213-5. Doi: 10.12968/jowc.2000.9.5.25985.
Lee YI, Kim J, Yang CE, Hong JW, Lee WJ, Lee JH. Combined Therapeutic Strategies for Keloid Treat-ment. Dermatol Surg. 2019;45(6):802-810
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Pakistan Association of Dermatologists
This work is licensed under a Creative Commons Attribution 4.0 International License.
